Drug product
Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
D-0190-2025
Product summary
- Event
- Event 96074
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 244,460 bottles
- Official record key
drug-enforcement:D-0190-2025
Official wording
Reason: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Code information: Lot # a) DT6023053A, DT6023061A, DT6023068A, DT6023074A, exp. date Jan-25; DT6023078A, DT6023076A, exp. date Feb-25; DTC24043A, DTC24044A, exp. date Dec-25 b) DT6023002A, DT6023016A, DT6023036A, exp. date Dec-24; DT6023048A, exp. date Jan-25
Distribution pattern: Nationwide
Derived failure modes
-
Foreign material or chemical contamination
N-nitroso-duloxetine impurity
-
Manufacturing or process control
CGMP Deviations